New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

MARGENZA (margetuximab-cmkb) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email to discuss.

Margenza (margetuximab-cmkb) is a medication used in combination with chemotherapy, to treat adults with metastatic HER2-positive breast cancer after at least two previous rounds of therapy.
DOSAGE FORMS & STRENGTHS: Injection: 250 mg/10 mL (25 mg/mL) in a single-dose vial.
Manufactured By: MacroGenics
Prescribing Information URL: Click Here

MARGENZA (margetuximab-cmkb) injection, a FDA approved prescription medicine can be accessed in India and other part of countries. South Delhi Pharma can facilitate the supply on request under Named Patient Program by fulfilling the legal requirement (if applicable) on behalf patient. Share your mobile number and email ID to get “margetuximab-cmkb injections” cost price in India.


Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Query Form


Medical Uses of margetuximab-cmkb injection

Margetuximab, is a chimeric IgG monoclonal antibody medication against HER2 used for the treatment of cancer.
The most common adverse drug reactions in combination with chemotherapy are fatigue/asthenia, nausea, diarrhea, vomiting, constipation, headache, pyrexia, alopecia, abdominal pain, peripheral neuropathy, arthralgia/myalgia, cough, decreased appetite, dyspnea, infusion-related reactions, palmar-plantar erythrodysesthesia, and extremity pain. Margetuximab is indicated, in combination with chemotherapy, for the treatment of adults with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.

Get Access To MARGENZA (margetuximab-cmkb) injection In India

Brand Name “MARGENZA (margetuximab-cmkb) injection” or Generic Name “margetuximab-cmkb injection” can be imported for personal use under “Named Patient Program” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at, or call/WhatsApp at +91-9891296838 to get access as per norms.

Related Products